cannabis
70% of cannabis consumers cannot separate fact from hype, and only five health claims - pain relief, anxiety reduction, insomnia improvement, nausea control, and seizure mitigation - are consistently supported by randomized trials. That alarming figure comes from a recent consumer study that compared advertised promises with peer-reviewed data. In
cannabis
Curaleaf or FDA: Who’s Actually Compliant on Cannabis Benefits? Only 37% of leading cannabis brands meet the FDA’s total cannabinoid label requirement as of Q1 2026, meaning the FDA - not Curaleaf - is the benchmark for compliance on cannabis benefit claims. The agency sets the legal standards;
cannabis
A 2025 trial found that low-THC, high-CBD cannabis improved memory consolidation by 27% in students who used it before sleep. The effect appears strongest when the product is taken about an hour before bedtime, allowing cannabinoids to interact with the brain’s overnight repair processes. In my work with campus
cannabis
An estimated 18% rise in tax liability is the hidden cost that is quietly plunging cannabis budgets. The change follows Executive Order 14067, which lifts tax advantages for hemp products and adds compliance expenses. Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult
cannabis
Try Cannabis Hemp Oil vs Conventional Farm Oil Cannabis hemp oil outperforms conventional farm oils on sustainability, absorbing up to 20% more CO₂ per acre and emitting roughly half the greenhouse gases of soybean oil. Its organic cultivation in Appalachia also trims water use and shortens supply chains, delivering a
cannabis
A 2021 study found a 35% reduction in muscle inflammation with 10 mg CBD, suggesting cannabis can match or exceed NSAID performance. In short, cannabis provides comparable anti-inflammatory benefits, lower side-effect risk, and reduced cost, though results depend on dosing and legal access. Legal Disclaimer: This content is for informational
cannabis
The lawsuit involves more than 200 complaints from consumers, doctors, and advocacy groups alleging false health claims in cannabis advertising. In the federal case, plaintiffs argue that many brands market cure-alls without FDA clearance, prompting a detailed legal challenge. Legal Disclaimer: This content is for informational purposes only and does
cannabis
7 High-Potency Strain Hazards That Stunt Cannabis Benefits High-potency cannabis strains raise pain levels by 38% and can trigger rapid tolerance, negating expected benefits. Recent analyses show that while patients seek stronger THC for relief, the excess potency often worsens discomfort and reduces anti-inflammatory effects. This trade-off reshapes how clinicians
cannabis
One in four cannabis product labels contains misleading benefit claims, meaning many consumers are sold exaggerated health promises. This article breaks down which claims have scientific backing, how new labeling rules aim to curb deception, and practical steps you can take to verify product claims before you buy. Medical Disclaimer:
cannabis
3 Hidden Scams in Cannabis Benefits Fueled Litigation The three hidden scams involve false medical claims, fabricated lab data, and misleading dosage information. Before you spend thousands on products touted as miracle cures, find out how 60% of advertised medical claims have been struck down in lawsuits. Medical Disclaimer: This
cannabis
Boost Mornings With Cannabis Hemp Oil A single tablespoon of hemp oil delivers roughly 2 grams of alpha-linolenic acid, doubling your omega-3 intake and lifting mood within the first week. Adding it to your first meal provides a quick, plant-based source of essential fats that supports brain function and steadies
cannabis
Curaleaf Lawsuit Uncovers Cannabis Benefits Misclaim Drops 27% The lawsuits caused a 12% drop in Curaleaf’s share price, yet they also highlight regulatory gaps that could spur a broader overhaul of the cannabis biotech sector. Investors see immediate losses, but policymakers may use the case to tighten labeling standards